Logo of Redica Systems

Redica Systems

Enforcement

Warning Letters Week of 07/19/20: Unapproved New Devices

Conference Spotlight

Hosting a Virtual FDA Inspection: Advice from Former FDA Investigator and Investigations Director Ricki Chase

Conference Spotlight

Preparing for a Virtual FDA Inspection: Advice from Former FDA Investigator and Investigations Director Ricki Chase

Enforcement

Warning Letters Week of 07/05/20: Supplier Qualification

Conference Spotlight

A State-of-the-Art Virtual Inspection Methodology Using Mixed Reality Technology Gets High Marks from European Medicines Agency Inspector

Enforcement

Warning Letters 06/28/20: Unapproved Vendors

Conference Spotlight

Yes, FDA is Still Performing Pharma Inspections, Using Risk-Based Criteria: What is Your Risk for Inspection?

Enforcement

FDA Warning Letters Week of 06/21/20: For-Cause Inspection & Untitled Letter From A 2018 Inspection

Conference Spotlight

Microbiological Issues with Aseptic Processing and Lyophilization: CGMP Inspection Case Study by FDA National Drug Expert Ileana Barreto-Pettit

Enforcement

Warning Letters Week of 06/14/20: Data Integrity

Conference Spotlight

Inadequate Media Fills at a Sterile Manufacturer When Starting up After a Shutdown: CGMP Inspection Case Study by FDA National Drug Expert Ileana Barreto-Pettit

Conference Spotlight

Cleaning and Cross-contamination Issues with an Encapsulator: CGMP Inspection Case Study by FDA National Drug Expert Ileana Barreto-Pettit

Conference Spotlight

David Doleski Encourages Industry to Participate in FDA’s Emerging Technology Efforts; Sanofi Case Study Reviewed

Trends

What is Risk-Based Thinking?

Enforcement

FDA Warning Letters Week of 05/24/20: Sterile Drugs, OTC Products, & Hiring of Quality Consultants

Conference Spotlight

Former FDA Official David Doleski on Agency Hot Button Issues and Developing a Positive Relationship

Enforcement

Warning Letters Week of 5/17/20

Enforcement

Warning Letters Week of 5/3/2020: 42 Concern COVID-19 Claims